The global breast implants market size was valued at USD 2.20 billion in 2022. It is projected to reach USD 4.68 billion by 2031, growing with a CAGR of 7.8% during the forecast period (2023–2031). A breast implant is a prosthesis used to change the size, shape, and contour of a woman’s breast. Breast implants are inserted to increase the size of the breasts, change their shape or make them level. Reconstructive plastic surgery is done to restore a natural-looking breast mound in post-mastectomy breast reconstruction patients or to correct congenital defects and deformities of the chest wall. Cosmetic surgery is done to enhance or enlarge the appearance of the breast through breast augmentation.
Increasing incidences of breast cancer are the key factor supporting the growth of the breast implant market. Mastectomy is usually carried out to treat breast cancer, and the desire to restore aesthetic appeal among patients will further drive the market growth of breast implants. Additionally, R&D initiatives and technological advancements, alongside increasing disposable income, are expected to contribute to market growth. On the other hand, the risk of developing serious complications and the lack of skilled nursing facilities in emerging markets may hamper the breast implants market growth.
Get more information on this report Download Sample Report
Increased Incidence of Breast Cancer
One of the key factors behind the expansion of this market is the increased incidence of breast cancer. In extreme circumstances, this condition can be prevented by undergoing a mastectomy, which entails the removal of the entire organ. Reconstruction of this organ is also seen to be a viable alternative for the treatment of this illness. In this process, the removed organ's shape is recreated. Rising obesity, consumption of alcohol, and tobacco use are increasing the risk of breast cancer. According to National Cancer Registry, by 2020, there will be approximately 5,000 new cases of breast cancer in Ireland per annum. As per the American Cancer Society, more than 266,120 new cases of breast cancer were registered in the U.S. alone in 2018. As a result, there will soon be greater demand for breast implantation due to the increase in reconstruction cases.
Risks Associated with the Surgery
Breast implant surgery may raise the likelihood of issues that will eventually require the removal of the implants because breast implants are not permanent. Tightening of the area around the implant is a common complication that may call for additional treatments or even implant removal. Breast augmentation surgeries are costly and frequently out of the price range of women with middle-class and lower-class incomes.
The global breast implants market can be segmented on the basis of product, application, and end user.
Based on the product, the market can be segmented into saline and silicone.
Amongst the segments by product, silicone is expected to record the highest growth during the forecast period. Compared to saline implants, these implants are less prone to wrinkle. The polyurethane-coated variety is said to reduce the possibility of implant rotation or the possibility that scar tissue will change the implant's form. However, if a soft gel silicone implant ruptures, silicone may disseminate into the breast and result in silicone granulomas. If the implant ruptures, it must be removed. Additionally, polyurethane-coated implants may cause a temporary skin reaction.
The saline segment is expected to witness rapid growth, owing to the increased preference towards saline breast implants among women. If the implants rupture, a salt-water saline solution contained within them can be safely absorbed or evacuated by the body. These implants are believed to be more prone to wrinkling or folding since they are less firm than silicone implants.
Based on application, the market can be segmented into breast augmentation and breast reconstruction.
Amongst the segments by application, breast augmentation is expected to account for the largest market share, owing to the increasing number of breast cosmetic surgical procedures around the globe. It is employed to enlarge the breasts. Artificial silicone or saline implants are typically used for this procedure.
The breast reconstruction segment is also expected to account for a significant share during the forecast period. Breast reconstruction restores the shape and appearance of breasts after mastectomy. It is most frequently performed in response to a breast cancer diagnosis or when the woman elects to have her breasts removed as a preventative step due to a high risk of developing breast cancer.
Based on end-user, the global market can be segmented into hospitals, dermatology clinics & cosmetic centers, and ambulatory surgical centers.
Amongst the segments by the end user, the hospital segment is anticipated to be the most lucrative throughout the forecast period, owing to the increasing number of advanced facilities for cosmetology surgeries. The dermatology clinics & cosmetic centers segment is also expected to witness healthy growth.
The geographical analysis of the market includes four major regions, North America, Europe, Asia Pacific (APAC), Middle East & Africa (LAMEA), and Latin America.
Regional Growth Insights Request Sample Pages
North America leads the breast implants market, owing to the increasing disposable income and growing awareness regarding breast-related cosmetic surgeries. According to the American Society of Plastic Surgeons (ASPS), breast augmentation is one of the top 5 cosmetic procedures in the U.S. A large number of such cases are expected to contribute to the growth of the market in the coming years. The breast reconstruction sector in North America is also benefiting from the existence of reimbursement regulations for the procedure. In the last two decades, there has been a significant rise in the incidence rate of breast cancer. In addition, breast cancer is the most frequent cancer in Canadian women, according to the Canadian Cancer Society. Many women choose mastectomy and lumpectomy treatments to reduce their risk of breast cancer; as a result, the demand for breast reconstruction procedures is expected to rise throughout the course of the projection period.
The Europe breast implants market is expected to account for a significant market share, owing to the high number of women undergoing cosmetic surgeries and the presence of major players in the region. For many diseases, including breast cancer, structured screening programs are encouraged throughout the European Union. Such activities are boosting the region's breast implant usage along with the growing acceptance of cosmetic surgery. In addition, with the rapid evolution of technology, the development of sophisticated breast implants has sped in terms of design, material, and fill volumes, minimizing negative patient outcomes, including implant wrinkling and rippling. Opportunities for industry expansion are being created by the availability of qualified plastic surgeons and the rising innovation of products.
The Asia Pacific breast implant market is expected to register the highest growth. Factors like rising breast cancer incidence rates in Asia Pacific and an increase in breast augmentation procedures in Asian nations can be linked to the expansion of the Asia Pacific breast implant market. On the other side, dangers connected with breast implants, such as breast soreness and infection, are anticipated to have a negative effect on the market. The need for cosmetic surgery has expanded significantly due to the Asia Pacific region's rapid economic development.
The Middle East & Africa breast implants market, is expected to experience significant growth owing to increasing medical tourism and the low cost of cosmetic surgeries in the region. Other factors positively influencing the market growth are growing healthcare and cosmetic infrastructure and supportive government initiatives. Latin America is expected to account for the least share in the global breast implant market due to poor healthcare and cosmetic infrastructure, low per capita income, and lack of awareness regarding breast cancer and breast augmentation surgeries. The breast implant market is driven by the rising incidence of breast cancer in Latin American nations. For instance, the WHO projects 22,024 additional instances of breast cancer in Argentina by 2020. As a result, there is a rising need for breast implantation due to the increase in reconstruction cases. The majority of implantable medical devices are pricy, which discourages people from having implantation surgery. In Mexico, the average price of breast augmentation surgery in 2021 was USD 4,300. Depending on the implant type, the surgeon's skill, and the reputation of the clinic, the starting price ranges from USD 2,500 to USD 8,000, while in Colombia, such an operation costs USD 5,000. The expense of screening tests, implants, surgical procedures, replacement or recurrence surgeries, and doctors' salaries all contribute to the financial burden of implantation surgery. One of the main obstacles limiting the growth of the breast implant market in Latin America is the patients' inability to choose expensive cosmetic operations.
Key players in the market are
|Market Size||USD in 4.68 billion By 2031|
|Forecast Units||Value (USD Billion)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends|
|Segments Covered||by Product (Saline and Silicone), Application (Breast Augmentation, Breast Reconstruction), End User (Hospitals)|
|Geographies Covered||North America, Europe, Asia-Pacific, LAME and Rest of the World|
|Key Companies Profiled/Vendors||Allergan Inc. (Actavis), CEREPLAS, Establishment Labs S.A., GC Aesthetics Plc., GROUPE SEBBIN SAS, Ideal Implant Inc., Hans Biomed Ltd, Laboratories Arion, Mentor Worldwide LLC. (A Johnson & Johnson Company), POLYTECH Health & Aesthetics GmbH, and Sientra, Inc.|
|Key Market Driver||Increased Incidence of Breast Cancer|